KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2016 - 2025)

CRISPR Therapeutics AG's Exchange Rate Effect history spans 11 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 101.15% year-over-year to $1000.0; the TTM value through Dec 2025 reached $95000.0, up 552.38%, while the annual FY2025 figure was $95000.0, 552.38% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $1000.0 at CRISPR Therapeutics AG, up from -$27000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $115000.0 in Q4 2022 and bottomed at -$100000.0 in Q3 2022.
  • The 5-year median for Exchange Rate Effect is $2500.0 (2021), against an average of $2800.0.
  • The largest annual shift saw Exchange Rate Effect crashed 1460.0% in 2022 before it skyrocketed 3900.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $3000.0 in 2021, then surged by 3733.33% to $115000.0 in 2022, then tumbled by 46.96% to $61000.0 in 2023, then tumbled by 242.62% to -$87000.0 in 2024, then soared by 101.15% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRSP's Exchange Rate Effect are $1000.0 (Q4 2025), -$27000.0 (Q3 2025), and $80000.0 (Q2 2025).